Viewing StudyNCT05770713



Ignite Creation Date: 2024-05-06 @ 6:45 PM
Last Modification Date: 2024-10-26 @ 2:54 PM
Study NCT ID: NCT05770713
Status: COMPLETED
Last Update Posted: 2023-04-21
First Post: 2023-03-05

Brief Title: A Real-life Study to Learn About the Use and Effects of the CDK46 Inhibitors in Canadian Patients With Breast Cancer
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
HRHER2- View
metastatic breast cancer View
advanced breast cancer View